We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8136:TSESanrio Co. Ltd. Analysis

Data as of 2026-03-11 - not real-time

¥5,637.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Sanrio’s share price is trading above its 20‑day and 50‑day simple moving averages but still below the 200‑day average, indicating short‑term momentum within a longer‑term neutral framework. The MACD line sits above its signal line with a positive histogram, delivering a bullish technical signal, while the RSI hovers in the mid‑50s, suggesting limited upside pressure. Volatility is elevated and trading volume has been trending lower, which raises the risk of sharp price swings. Fundamentally, the company posts strong operating margins and a robust revenue growth rate, yet the price‑to‑earnings and price‑to‑book multiples are high, hinting at potential overvaluation. Cash flow generation is currently nil, and the debt‑to‑equity ratio is elevated, casting doubt on the sustainability of its modest dividend yield. Overall, the stock presents a mixed picture: solid earnings growth and brand strength offset by high valuation, weak cash fundamentals, and heightened short‑term price volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD crossover supporting near‑term upside
  • Price above short‑term SMAs indicating momentum
  • High volatility and decreasing volume raising downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong operating margin and revenue growth driving earnings
  • Elevated valuation multiples limiting upside potential
  • Zero operating cash flow and high leverage increasing financial risk

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Persistent overvaluation relative to earnings and book value
  • Cash flow deficiencies and debt burden threatening dividend sustainability
  • High long‑term volatility and low beta suggesting limited market upside

Key Metrics & Analysis

Financial Health

Revenue Growth32.30%
P/E Ratio27.3
Debt/Equity11.12
P/B Ratio9.9

Technical Analysis

TrendNeutral
RSI56.8
Support¥4,681.00
Resistance¥6,179.00
MA 20¥5,492.25
MA 50¥5,098.56
MA 200¥6,250.89
MACDBullish
VolumeDecreasing
Fear & Greed Index78.16

Valuation

Target Price¥7,599.14
Upside/Downside34.81%
GradeOvervalued
TypeGrowth
Dividend Yield1.18%

Risk Assessment

Beta0.32
Volatility58.85%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.